Cue Biopharma
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
MARLETT CHRISTOPHER A director
 Common Stock 17,200 $4.53 $77,916
Purchase
DIGIANDOMENICO ANTHONY director
 Common Stock 10,000 $4.49 $44,900
Purchase
MARLETT CHRISTOPHER A director
 Common Stock 9,438 $4.74 $44,736
Purchase
MARLETT CHRISTOPHER A director
 Common Stock 400 $5 $2,000
Purchase
MARLETT CHRISTOPHER A director
 Common Stock 3,664 $5.2 $19,053
Purchase
DIGIANDOMENICO ANTHONY director
 Common Stock 10,000 $5.48 $54,800
Purchase
MARLETT CHRISTOPHER A director
 Common Stock 10,000 $5.06 $50,600
Purchase
MARLETT CHRISTOPHER A director
 Common Stock 12,189 $5.08 $61,920
Purchase
MARLETT CHRISTOPHER A director
 Common Stock 7,543 $4.86 $36,659
Purchase
MILLAR KERRI-ANN officer: CFO
 Common Stock 1,000 $8.48 $8,480
Purchase
PASSERI DANIEL R director, officer: CEO
 Common Stock 6,000 $8.09 $48,510
Purchase
PASSERI DANIEL R director, officer: CEO
 Common Stock 1,600 $11.97 $19,152
Option
MARLETT CHRISTOPHER A director
 Stock Option (right to buy) 8,000 $14.24 $113,920
Option
DIGIANDOMENICO ANTHONY director
 Stock Option (right to buy) 8,000 $14.24 $113,920
Option
MCKNIGHT STEVEN L director
 Stock Option (right to buy) 8,000 $14.24 $113,920
Option
KIENER PETER A director
 Stock Option (right to buy) 9,600 $14.24 $136,704
Option
GRAY CAMERON director
 Stock Option (right to buy) 8,000 $14.24 $113,920
Option
SIMON BARRY J. director
 Stock Option (Right to Buy) 8,000 $14.24 $113,920
Purchase
PIENTA KENNETH officer: Chief Medical Officer
 Common Stock 2,000 $7.5 $15,000

Showing 100 to 119 of 119 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: